Citadel Advisors’s AN2 Therapeutics ANTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.2K | Buy |
+12,497
| New | +$13.2K | ﹤0.01% | 5668 |
|
|
2025
Q1 | – | Sell |
-67,994
| Closed | -$93.8K | – | 5910 |
|
|
2024
Q4 | $93.8K | Buy |
+67,994
| New | +$93.8K | ﹤0.01% | 5224 |
|
|
2024
Q3 | – | Sell |
-1,553,829
| Closed | -$3.34M | – | 5755 |
|
|
2024
Q2 | $3.34M | Sell |
1,553,829
-2,725
| -0.2% | -$5.86K | ﹤0.01% | 1988 |
|
|
2024
Q1 | $5.06M | Sell |
1,556,554
-288
| -0% | -$936 | ﹤0.01% | 1748 |
|
|
2023
Q4 | $31.9M | Buy |
1,556,842
+290
| +0% | +$5.94K | 0.01% | 650 |
|
|
2023
Q3 | $25M | Buy |
1,556,552
+219,569
| +16% | +$3.53M | 0.01% | 691 |
|
|
2023
Q2 | $11.4M | Sell |
1,336,983
-176
| -0% | -$1.5K | ﹤0.01% | 1127 |
|
|
2023
Q1 | $13.2M | Buy |
1,337,159
+176
| +0% | +$1.74K | ﹤0.01% | 1123 |
|
|
2022
Q4 | $12.7M | Hold |
1,336,983
| – | – | ﹤0.01% | 1132 |
|
|
2022
Q3 | $23.2M | Buy |
1,336,983
+3,167
| +0.2% | +$55K | 0.01% | 741 |
|
|
2022
Q2 | $9.92M | Sell |
1,333,816
-86,035
| -6% | -$640K | ﹤0.01% | 1289 |
|
|
2022
Q1 | $20.6M | Buy |
+1,419,851
| New | +$20.6M | ﹤0.01% | 898 |
|